HRMY

Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)

About Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.

Details

Daily high

$34.78

Daily low

$34.19

Price at open

$34.46

52 Week High

$41.61

52 Week Low

$26.47

Market cap

2.0B

Dividend yield

0.00%

Volume

498,980

Avg. volume

621,987

P/E ratio

12.96

Harmony Biosciences Holdings, Inc. - Common Stock News